CN112617196A - 一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途 - Google Patents
一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN112617196A CN112617196A CN202011359324.6A CN202011359324A CN112617196A CN 112617196 A CN112617196 A CN 112617196A CN 202011359324 A CN202011359324 A CN 202011359324A CN 112617196 A CN112617196 A CN 112617196A
- Authority
- CN
- China
- Prior art keywords
- parts
- food
- health
- care product
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010021143 Hypoxia Diseases 0.000 title claims abstract description 48
- 235000013305 food Nutrition 0.000 title claims abstract description 47
- 206010002660 Anoxia Diseases 0.000 title claims abstract description 21
- 241000976983 Anoxia Species 0.000 title claims abstract description 17
- 230000007953 anoxia Effects 0.000 title claims abstract description 17
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 102000009027 Albumins Human genes 0.000 claims abstract description 13
- 108010088751 Albumins Proteins 0.000 claims abstract description 13
- 241000620196 Arthrospira maxima Species 0.000 claims abstract description 13
- 235000020235 chia seed Nutrition 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 230000002929 anti-fatigue Effects 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 9
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 8
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 8
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 230000001154 acute effect Effects 0.000 claims abstract description 6
- 230000001684 chronic effect Effects 0.000 claims abstract description 6
- 208000024891 symptom Diseases 0.000 claims abstract description 6
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 3
- 239000000047 product Substances 0.000 claims description 44
- 230000036541 health Effects 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- 241000229143 Hippophae Species 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- 235000013924 ferrous gluconate Nutrition 0.000 claims description 7
- 239000004222 ferrous gluconate Substances 0.000 claims description 7
- 229960001645 ferrous gluconate Drugs 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 claims description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 210000004556 brain Anatomy 0.000 claims description 5
- 210000000748 cardiovascular system Anatomy 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 235000001727 glucose Nutrition 0.000 claims description 5
- 230000001146 hypoxic effect Effects 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 229960001031 glucose Drugs 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000003935 Hippophae Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 210000003169 central nervous system Anatomy 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000002417 nutraceutical Substances 0.000 claims 4
- 235000021436 nutraceutical agent Nutrition 0.000 claims 4
- 241000208340 Araliaceae Species 0.000 claims 3
- 235000013361 beverage Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 230000007954 hypoxia Effects 0.000 description 13
- 240000004371 Panax ginseng Species 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 238000012549 training Methods 0.000 description 4
- 240000002624 Mespilus germanica Species 0.000 description 3
- 235000017784 Mespilus germanica Nutrition 0.000 description 3
- 235000000560 Mimusops elengi Nutrition 0.000 description 3
- 235000007837 Vangueria infausta Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000382353 Pupa Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007105 physical stamina Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 241000813872 Oscillatoriaceae Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- 208000008445 altitude sickness Diseases 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
本发明提供了一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途。该组合物是由如下重量配比的原料制备而成的食品、保健品或药物制剂:人参24~36份、黄精80~120份、蛹虫草16~24份、白蛋白肽16~24份、极大螺旋藻16~24份、奇亚籽16~24份、枸杞子16~24份、沙棘16~24份、维生素C 0.1~1份。本发明组合物配伍合理,对于抗疲劳、抗氧化发挥了协同增效作用;还可以用于缓解高原反应,预防急慢性高原缺氧疾病。同时,本发明组合物使用的原料安全无毒副作用,可提供安全高效的能量补给,增强机体对缺氧环境的耐受能力,有效缓解机体缺氧反应等症状,具有良好的应用前景。
Description
技术领域
本发明涉及一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途。
背景技术
高原系指海拔在3000m以上的地区,包括高山和高原。高原空气稀薄,大气压低,氧分分压低,易使人缺氧。在高原旅游和工作的人,由于对高原缺氧环境不适应,体能消耗快,容易出现缺氧、疲劳、高原反应等症状。
同时,竞技体育领域,成绩的提高以及体能的提高离不开训练,而大强度、大运动量的体育训练和体能训练导致的一个主要问题就是机体供氧不足,氧的利用率不高,细胞以及组织的缺氧导致机体乳酸水平升高,导致肌体的运动能力下降,进而影响运动训练的展开,严重的导致肌体疲劳积累,影响身体健康。提高肌体的抗缺氧能力也是十分关键。
对于这些人员提供安全高效的能力补给,快速补充体能,增强机体对缺氧环境的耐受能力具有重要意义。
目前,存在的提高肌体抗疲劳抗缺氧的药物较多,如黄精、人参、蛹虫草等等,但是单味药的抗疲劳、抗缺氧效果不理想。专利CN109550040A公开了一种由蚕蛹培育虫草、蚕蛹冲草菌丝体、肉苁蓉。黑玛卡、黑桑葚、黑枸杞、人参、松茸、黄秋葵、黄精、覆盆子、益智仁、茯苓、大豆肽、枸杞肽、蚕蛹蛋白肽组成的抗疲劳、抗缺氧的多肽组合物。
但是,目前尚未见本发明组合物用于抗疲劳、抗缺氧。
发明内容
本发明的目的是提供一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途。
本发明提供了一种抗缺氧、抗疲劳的食品、保健品或药物组合物,它是由如下重量配比的原料制备而成的食品、保健品或药物制剂:人参24~36份、黄精80~120份、蛹虫草16~24份、白蛋白肽16~24份、极大螺旋藻16~24份、奇亚籽16~24份、枸杞子16~24份、沙棘16~24份、维生素C 0.1~1份。
进一步地,前述的食品、保健品或药物组合物是由如下重量配比的原料制备而成的食品、保健品或药物制剂:人参30份、黄精100份、蛹虫草20份、白蛋白肽20份、极大螺旋藻20份、奇亚籽20份、枸杞子20份、沙棘20份、维生素C 0.5份。
进一步地,前述的食品、保健品或药物组合物是由各重量配比原料的粉末、或水或有机溶剂提取物,加入食品、保健品或药物上可接受的辅料或者辅助性成分制备而成的食品、保健品或药物制剂;
优选地,所述辅料包括葡萄糖、木糖醇、葡萄糖酸亚铁和山梨酸钾;
更优选地,所述辅料的重量配比如下:葡萄糖20份、木糖醇20份、葡萄糖酸亚铁0.02份、山梨酸钾0.1份。
进一步地,所述药物制剂为口服制剂。
进一步地,所述食品或保健品为饮品。
本发明还提供了一种制备前述的食品、保健品或药物组合物的方法,它包括如下步骤:取各重量配比的原料,直接打粉,或者加入水或有机溶剂提取,再加入食品、保健品或药物上可接受的辅料或者辅助性成分,即得。
进一步地,前述的方法包括如下步骤:
(1)按照重量配比称取黄精、人参、蛹虫草、奇亚籽、枸杞子、沙棘、极大螺旋藻,加入纯化水煎煮,得提取滤液;
(2)将白蛋白肽、食用葡萄糖、木糖醇、维生素C、葡萄糖酸亚铁溶于纯化水中,溶解后过滤,得提取滤液;
(3)将步骤(1)和步骤(2)得到的滤液合并,加入食品、保健品或药物上可接受的辅料或者辅助性成分,即得;
优选地,
步骤(1)中,所述煎煮为煎煮两次,第一次加入5倍量(v/w)的纯化水,80℃煎煮2小时;第二次加入3倍量(v/w)的纯化水,80℃煎煮1小时。
本发明还提供了前述的食品、保健品或药物组合物在制备抗疲劳和/或抗缺氧的食品、保健品或药物制剂的用途。
进一步地,所述食品、保健品或药物制剂为能缓解高原反应症状的食品、保健品或药物制剂。
进一步地,所述食品、保健品或药物制剂为预防急慢性高原缺氧疾病的食品、保健品或药物制剂;
优选地,所述食品、保健品或药物制剂为预防大脑中枢统和心血管系统的缺氧疾病的食品、保健品或药物制剂。
本发明中,v/w是指mL/g。
本发明中,蛹虫草为子囊菌门,肉座目,麦角菌科、虫草属的模式种。学名为Cordyceps militaris(L.ex Fr.)Link.蛹虫草,又叫北冬虫夏草,北虫草,简称蛹草。
白蛋白肽又叫白蛋白多肽。
极大螺旋藻是一类低等值物,属于蓝藻门,颤藻科,螺旋藻属,是螺旋藻的一种。
奇亚籽是薄荷类植物芡欧鼠尾草(Salvia Hispanica L.)的种子。
本发明原料中各味药应符合《中国药典》2010版一部相应药材项下的各项规定。
成品均参照药典及相关文献筛选各味药的薄层鉴别条件,如提取溶剂,提取方法,提取时间以及展开系统等。参照《中国药典》2010年版一部附录IJ口服液体制剂项下有关的各项规定。检查装量差异、微生物限度、澄清度等。并根据成品制剂的具体性状制定本品的相对密度、PH等标准。
本发明组合物配伍合理,对于抗疲劳、抗氧化发挥了协同增效作用,可显著清除乳酸堆积,提高耐氧力。此外,本发明组合物不仅可以提高机体能源物质储备、减少代谢产物的累积从而起到抗缺氧、抗疲劳作用;还可以用于缓解高原反应,预防急慢性高原缺氧疾病,尤其是对低氧最为敏感的大脑中枢统和心血管系统的缺氧疾病。同时,本发明组合物使用的原料均可以药食同源,安全无毒副作用。因此,本发明组合可提供安全高效的能量补给,快速补充体能,增强机体对缺氧环境的耐受能力,有效缓解机体缺氧反应等症状。适宜于所有人群,尤其是高原缺氧低气压特殊环境下工作者、旅游者、高强度运动员、体力劳动者、无氧运动爱好者、免疫力较弱者。具有良好的应用前景。
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。
具体实施方式
本发明具体实施方式中使用的原料、设备均为已知产品,通过购买市售产品获得。
实施例1、本发明组合物的制备
1、原料
人参30g、黄精100g、蛹虫草20g、白蛋白肽20g、极大螺旋藻20g、奇亚籽20g、枸杞子20g、沙棘20g、维生素C 0.5g。
2、制备方法
上述配方中的原料药黄精、人参、蛹虫草、奇亚籽、枸杞子、沙棘、极大螺旋藻均经严格的筛选标准,筛选出质量上乘的药品。具体制备方法如下:
(1)按照上述重量,将黄精、人参、蛹虫草、奇亚籽、枸杞子、沙棘、极大螺旋藻与总药量5倍量(v/w)的纯化水,加热至80℃煎煮2小时,将提取液收集容器内;再在药渣中加入总药量3倍量(v/w)的纯化水,80℃煎煮1小时,另取容器收集提取液;将两次提取液收集在同一容器内,充分搅拌均匀,过滤,提取滤液。
(2)同时将白蛋白肽、维生素C和辅料食用葡萄糖20g、木糖醇20g、葡萄糖酸亚铁0.02g与总量同等倍量(v/w)的纯化水,置于60℃高温下,将固体充分溶解为液体后,经过过滤,提取滤液。
(3)将步骤(1)和步骤(2)两次获得的滤液充分混合,加入辅料枸橼糖浆、山梨酸钾0.1g,充分搅拌均匀,经罐装、灭菌、包装、检验,即得。
实施例2、本发明组合物的制备
1、原料
人参36g、黄精120g、蛹虫草24g、白蛋白肽24g、极大螺旋藻24g、奇亚籽24g、枸杞子24g、沙棘24g、维生素C1g。
2、制备方法
同实施例1。
实施例3、本发明组合物的制备
1、原料
人参24g、黄精80g、蛹虫草16g、白蛋白肽16g、极大螺旋藻16g、奇亚籽16g、枸杞子16g、沙棘16g、维生素C 0.1g。
2、制备方法
同实施例1。
以下通过具体的试验例证明本发明的有益效果。
试验例1、本发明组合物对小鼠模拟高原抗缺氧作用的影响
一、实验方法
1.材料:
(1)KM小鼠30只,雌雄各半,体重100~150g,随机分为3组,即常氧对照组、模拟高原缺氧组(缺氧组)、本发明组合物(实施例1)预防加缺氧组(实验组),每组10只。
(2)本发明实施例1制备的组合物使用前用生理盐水配成终浓度0.5g/ml。
2.动物处理:给药方法:实验组按0.5ml/100g体重剂量每天灌胃给1次,连续7天;其余两组给予等体积的生理盐水,连续7天。7天后将缺氧组及实验组同时置于实验室采用小型减压舱模拟海拔8000m高原的低氧环境中,造成小鼠缺氧环境。对照组断头处死,其余两组(缺氧组和实验组)缺氧致死,小鼠死后即刻取血,血液离心取血清化验。
3.统计学处理:每组实验结果用X±s表示,用方差分析和t检验比较三组均数之间的差异显著性。
二、实验结果
各组小鼠血清乳酸的含量及存活时间的比较见表1。由表1可知:缺氧组血清乳酸含量明显高于对照组(P<0.01);而利用本发明组合物(实验组)预处理后可显著降低血清乳酸含量(P<0.01),显著延长存活时间(P<0.01)。
表1.各组小鼠血清乳酸的含量及存活时间的比较
组别 | N | 乳酸mmol/L | 存活时间(s) |
对照组 | 10 | 9.40±0.94 | - |
缺氧组 | 10 | 11.89±1.18* | 936.90±76.04 |
实验组 | 10 | 10.35±1.12** | 1192.00±326.27** |
*与对照组相比P<0.01;**与缺氧组相比P<0.01
本研究通过小鼠常氧及模拟高原缺氧实验评价了本发明组合物对小鼠的耐缺氧作用。由上述实验结果可知:本发明组合物可显著清除乳酸堆积,具有抗疲劳作用;同时,本发明组合物显著提高耐氧力,延长存活时间。本发明组合物配伍使用后,对于抗疲劳、抗氧化发挥了协同增效作用,效果优于相同剂量下单独使用各原料。本发明组合物不仅可以提高机体能源物质储备、减少代谢产物的累积从而起到抗缺氧、抗疲劳作用;还可以用于缓解高原反应,预防急慢性高原缺氧疾病,尤其是对低氧最为敏感的大脑中枢统和心血管系统的缺氧疾病。
综上,本发明组合物配伍合理,对于抗疲劳、抗氧化发挥了协同增效作用,可显著清除乳酸堆积,提高耐氧力。此外,本发明组合物不仅可以提高机体能源物质储备、减少代谢产物的累积从而起到抗缺氧、抗疲劳作用;还可以用于缓解高原反应,预防急慢性高原缺氧疾病,尤其是对低氧最为敏感的大脑中枢统和心血管系统的缺氧疾病。同时,本发明组合物使用的原料均可以药食同源,安全无毒副作用。因此,本发明组合可提供安全高效的能量补给,快速补充体能,增强机体对缺氧环境的耐受能力,有效缓解机体缺氧反应等症状。适宜于所有人群,尤其是高原缺氧低气压特殊环境下工作者、旅游者、高强度运动员、体力劳动者、无氧运动爱好者、免疫力较弱者。具有良好的应用前景。
Claims (10)
1.一种抗缺氧、抗疲劳的食品、保健品或药物组合物,其特征在于:它是由如下重量配比的原料制备而成的食品、保健品或药物制剂:人参24~36份、黄精80~120份、蛹虫草16~24份、白蛋白肽16~24份、极大螺旋藻16~24份、奇亚籽16~24份、枸杞子16~24份、沙棘16~24份、维生素C 0.1~1份。
2.根据权利要求1所述的食品、保健品或药物组合物,其特征在于:它是由如下重量配比的原料制备而成的食品、保健品或药物制剂:人参30份、黄精100份、蛹虫草20份、白蛋白肽20份、极大螺旋藻20份、奇亚籽20份、枸杞子20份、沙棘20份、维生素C 0.5份。
3.根据权利要求1或2所述的食品、保健品或药物组合物,其特征在于:它是由各重量配比原料的粉末、或水或有机溶剂提取物,加入食品、保健品或药物上可接受的辅料或者辅助性成分制备而成的食品、保健品或药物制剂;
优选地,所述辅料包括葡萄糖、木糖醇、葡萄糖酸亚铁和山梨酸钾;
更优选地,所述辅料的重量配比如下:葡萄糖20份、木糖醇20份、葡萄糖酸亚铁0.02份、山梨酸钾0.1份。
4.根据权利要求3所述的食品、保健品或药物组合物,其特征在于:所述药物制剂为口服制剂。
5.根据权利要求3所述的食品、保健品或药物组合物,其特征在于:所述食品或保健品为饮品。
6.一种制备权利要求1~5任一项所述的食品、保健品或药物组合物的方法,其特征在于:它包括如下步骤:取各重量配比的原料,直接打粉,或者加入水或有机溶剂提取,再加入食品、保健品或药物上可接受的辅料或者辅助性成分,即得。
7.根据权利要求6所述的方法,其特征在于:它包括如下步骤:
(1)按照重量配比称取黄精、人参、蛹虫草、奇亚籽、枸杞子、沙棘、极大螺旋藻,加入纯化水煎煮,得提取滤液;
(2)将白蛋白肽、食用葡萄糖、木糖醇、维生素C、葡萄糖酸亚铁溶于纯化水中,溶解后过滤,得提取滤液;
(3)将步骤(1)和步骤(2)得到的滤液合并,加入食品、保健品或药物上可接受的辅料或者辅助性成分,即得;
优选地,
步骤(1)中,所述煎煮为煎煮两次,第一次加入5倍量(v/w)的纯化水,80℃煎煮2小时;第二次加入3倍量(v/w)的纯化水,80℃煎煮1小时。
8.权利要求1~5任一项所述的食品、保健品或药物组合物在制备抗疲劳和/或抗缺氧的食品、保健品或药物制剂的用途。
9.根据权利要求8所述的用途,其特征在于:所述食品、保健品或药物制剂为能缓解高原反应症状的食品、保健品或药物制剂。
10.根据权利要求8所述的用途,其特征在于:所述食品、保健品或药物制剂为预防急慢性高原缺氧疾病的食品、保健品或药物制剂;
优选地,所述食品、保健品或药物制剂为预防大脑中枢统和心血管系统的缺氧疾病的食品、保健品或药物制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011359324.6A CN112617196A (zh) | 2020-11-27 | 2020-11-27 | 一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011359324.6A CN112617196A (zh) | 2020-11-27 | 2020-11-27 | 一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112617196A true CN112617196A (zh) | 2021-04-09 |
Family
ID=75306573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011359324.6A Pending CN112617196A (zh) | 2020-11-27 | 2020-11-27 | 一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112617196A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112617197A (zh) * | 2020-11-27 | 2021-04-09 | 成都藏源高能生物科技有限公司 | 一种抗缺氧的食品、保健品或药物组合物及其制备方法和用途 |
CN114468310A (zh) * | 2022-02-25 | 2022-05-13 | 河北御芝林生物科技有限公司 | 一种提高免疫力的肽组合物及其制备方法 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147357A (zh) * | 2014-08-19 | 2014-11-19 | 河北省体育科学研究所 | 一种复方虫草口服制剂及其制备 |
CN104489647A (zh) * | 2014-11-28 | 2015-04-08 | 江苏天美健大自然生物工程有限公司 | 一种含黄芪、杜仲、黄精、沙棘、人参的抗疲劳保健食品及其制备方法 |
CN104873761A (zh) * | 2015-05-06 | 2015-09-02 | 福建天斯顿生物科技有限公司 | 一种蛹虫草复方制品及其制备方法 |
CN106036876A (zh) * | 2016-06-29 | 2016-10-26 | 武汉枫阳生物科技有限公司 | 一种增强免疫力的食品 |
CN107095295A (zh) * | 2017-04-23 | 2017-08-29 | 陈永红 | 一种提升肾功能和血液功能的植物复合粉或片剂 |
CN109550040A (zh) * | 2019-01-22 | 2019-04-02 | 广西壮仁堂生物科技有限公司 | 一种增强免疫力的中药多肽组合物 |
CN110833188A (zh) * | 2019-11-15 | 2020-02-25 | 浙江一鸣食品股份有限公司 | 一种制备酵素的工艺及利用其制备的酵素 |
CN111227258A (zh) * | 2020-03-09 | 2020-06-05 | 中科花鹿农业发展有限公司 | 一种牡蛎肽含片及其制作方法 |
CN111588833A (zh) * | 2020-07-09 | 2020-08-28 | 北京大元藏宝堂健康管理有限公司 | 一种调节高血压的产品 |
CN112617197A (zh) * | 2020-11-27 | 2021-04-09 | 成都藏源高能生物科技有限公司 | 一种抗缺氧的食品、保健品或药物组合物及其制备方法和用途 |
-
2020
- 2020-11-27 CN CN202011359324.6A patent/CN112617196A/zh active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147357A (zh) * | 2014-08-19 | 2014-11-19 | 河北省体育科学研究所 | 一种复方虫草口服制剂及其制备 |
CN104489647A (zh) * | 2014-11-28 | 2015-04-08 | 江苏天美健大自然生物工程有限公司 | 一种含黄芪、杜仲、黄精、沙棘、人参的抗疲劳保健食品及其制备方法 |
CN104873761A (zh) * | 2015-05-06 | 2015-09-02 | 福建天斯顿生物科技有限公司 | 一种蛹虫草复方制品及其制备方法 |
CN106036876A (zh) * | 2016-06-29 | 2016-10-26 | 武汉枫阳生物科技有限公司 | 一种增强免疫力的食品 |
CN107095295A (zh) * | 2017-04-23 | 2017-08-29 | 陈永红 | 一种提升肾功能和血液功能的植物复合粉或片剂 |
CN109550040A (zh) * | 2019-01-22 | 2019-04-02 | 广西壮仁堂生物科技有限公司 | 一种增强免疫力的中药多肽组合物 |
CN110833188A (zh) * | 2019-11-15 | 2020-02-25 | 浙江一鸣食品股份有限公司 | 一种制备酵素的工艺及利用其制备的酵素 |
CN111227258A (zh) * | 2020-03-09 | 2020-06-05 | 中科花鹿农业发展有限公司 | 一种牡蛎肽含片及其制作方法 |
CN111588833A (zh) * | 2020-07-09 | 2020-08-28 | 北京大元藏宝堂健康管理有限公司 | 一种调节高血压的产品 |
CN112617197A (zh) * | 2020-11-27 | 2021-04-09 | 成都藏源高能生物科技有限公司 | 一种抗缺氧的食品、保健品或药物组合物及其制备方法和用途 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112617197A (zh) * | 2020-11-27 | 2021-04-09 | 成都藏源高能生物科技有限公司 | 一种抗缺氧的食品、保健品或药物组合物及其制备方法和用途 |
CN114468310A (zh) * | 2022-02-25 | 2022-05-13 | 河北御芝林生物科技有限公司 | 一种提高免疫力的肽组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2013538219A (ja) | 漢方薬組成物の、肉体疲労の緩和及び予防治療のための健康食品や医薬品の調製への応用 | |
KR20100127420A (ko) | 사포닌의 생체 이용률 증진 조성물 | |
CN111035649A (zh) | 一种nmn+glp复配营养补充剂及其制备方法和应用 | |
CN112617196A (zh) | 一种抗缺氧、抗疲劳的食品、保健品或药物组合物及其制备方法和用途 | |
CN108014150B (zh) | 天然药物组合物在制备抗缺氧和抗辐射的药物或食品中的应用 | |
CN112569305A (zh) | 一种提高免疫力的香菇复合多糖组合物及其制备方法 | |
CN103355655A (zh) | 一种具有改善营养性贫血功能的组合物及其制备方法 | |
CN112841644A (zh) | 一种人参核桃低聚肽粉及其制备方法 | |
CN101336709A (zh) | 一种抗疲劳营养制剂 | |
CN112617197A (zh) | 一种抗缺氧的食品、保健品或药物组合物及其制备方法和用途 | |
CN105998140B (zh) | 红景天含片 | |
CN105233250B (zh) | 一种用于治疗脑病的复合生物制剂 | |
CN102726731A (zh) | 抗辐射食品及其生产工艺 | |
CN109157548B (zh) | 一种具有抗疲劳和壮阳功能的组合物及制备方法 | |
CN102631492B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN107536016B (zh) | 一种保护心脏和促进肝脏健康的营养食品 | |
CN111346172B (zh) | 一种提高免疫力的药物组合物 | |
CN110559354A (zh) | 一种复方红景天组合物及其制备方法 | |
CN105168519B (zh) | 具有改善睡眠功能的组合物及其制备方法和应用 | |
CN102526370A (zh) | 提高人体免疫功能的虫草制剂及其制备方法 | |
CN102631506B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN103860761A (zh) | 一种提高免疫抗疲劳的药物组合物及其制备方法和应用 | |
CN115607629B (zh) | 一种具有保肝解酒的中药组合物及其制备方法 | |
CN108567811B (zh) | 一种具有抗疲劳、免疫调节功能的组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210409 |